A combination of buprenorphine and naltrexone blocks compulsive cocaine intake in rodents without producing dependence
about
Naltrexone HCI/bupropion HCI for chronic weight management in obese adults: patient selection and perspectivesSelf-administration of ethanol, cocaine, or nicotine does not decrease the soma size of ventral tegmental area dopamine neuronsEffects of the kappa opioid receptor antagonist nor-binaltorphimine (nor-BNI) on cocaine versus food choice and extended-access cocaine intake in rhesus monkeys.The effects of amphetamine, butorphanol, and their combination on cocaine self-administration.Buprenorphine + naloxone plus naltrexone for the treatment of cocaine dependence: the Cocaine Use Reduction with Buprenorphine (CURB) study.The opioid receptors as targets for drug abuse medicationNovel approaches for the treatment of psychostimulant and opioid abuse - focus on opioid receptor-based therapies.Synthesis and characterization of a dual kappa-delta opioid receptor agonist analgesic blocking cocaine reward behaviorNociceptin receptor activation does not alter acquisition, expression, extinction and reinstatement of conditioned cocaine preference in miceThe macrocyclic tetrapeptide [D-Trp]CJ-15,208 produces short-acting κ opioid receptor antagonism in the CNS after oral administration.Combination of Levo-Tetrahydropalmatine and Low Dose Naltrexone: A Promising Treatment for Prevention of Cocaine Relapse.Substance use disorders: psychoneuroimmunological mechanisms and new targets for therapy.Cocaine use reduction with buprenorphine (CURB): rationale, design, and methodology.Systemic Delivery of a Brain-Penetrant TrkB Antagonist Reduces Cocaine Self-Administration and Normalizes TrkB Signaling in the Nucleus Accumbens and Prefrontal Cortex.The biology of Nociceptin/Orphanin FQ (N/OFQ) related to obesity, stress, anxiety, mood, and drug dependence.Utility of Nonhuman Primates in Substance Use Disorders Research.Buprenorphine requires concomitant activation of NOP and MOP receptors to reduce cocaine consumption.Insights from Preclinical Choice Models on Treating Drug Addiction.Modulation of drug choice by extended drug access and withdrawal in rhesus monkeys: Implications for negative reinforcement as a driver of addiction and target for medications development.Hypocretin Neurotransmission Within the Central Amygdala Mediates Escalated Cocaine Self-administration and Stress-Induced Reinstatement in Rats.Kappa-Opioid Antagonists for Psychiatric Disorders: From Bench to Clinical Trials.Cebranopadol Blocks the Escalation of Cocaine Intake and Conditioned Reinstatement of Cocaine Seeking in Rats.Cebranopadol, a Mixed Opioid Agonist, Reduces Cocaine Self-administration through Nociceptin Opioid and Mu Opioid Receptors.A non-rewarding, non-aversive buprenorphine/naltrexone combination attenuates drug-primed reinstatement to cocaine and morphine in rats in a conditioned place preference paradigm.Knockdown of hypocretin attenuates extended access of cocaine self-administration in rats.
P2860
Q26746239-8CCE903C-D69D-495B-B024-C6BF2CEDE79CQ28538136-BD7AD97F-5C51-4A76-9CC6-C00AED6BD85CQ30362023-1CCB1A51-AC6A-4EC9-A725-8642853F38A9Q34266499-3BE5415F-CB37-42A5-B299-041ADE9633B2Q34517116-B8EBE8CF-48DB-4CB6-B240-28835E5A879CQ35978068-C8ACAE36-BD4A-430F-9825-BBA00BE7D429Q36104010-10B97A36-D0C5-4455-8EC3-D5161614839FQ36296493-8D8F5F27-D7C4-4884-906E-DC825E7247FDQ36521971-D18521EE-7B64-4AC5-ABA2-391556C3E837Q36836438-2CB65671-9A87-46C1-AF54-EC63C215A7B6Q36852570-E9A4B9DD-99FF-4EFC-9399-5B00853DF1AFQ37052393-519D6717-C85C-493C-9820-F34A7CACB9C3Q37140536-6CA59605-1837-4DC1-9234-574A9497FEB0Q37147592-52943170-CD53-4AFF-A881-833A635494BEQ37397573-CD0CC4A6-E5AD-48D6-AAF5-57493EAEF0D6Q38680773-495A3BD6-B5B8-4514-A8D5-D8F0F339504EQ38716082-D327AA94-D241-4256-97B6-53274FB16739Q39028819-AF384299-E160-481C-BF9B-62648793459AQ39262233-FB7F7466-D15E-4BEF-8C1E-D6DCA2D9CE59Q39447778-7B353634-DD3F-4CDE-BCF1-2170ED6AFCD9Q41639865-6C6C0C3A-579B-43E7-9F5D-A8D1EBB1BCC4Q44474417-6ED7473E-19AE-4C5D-A559-3A2D57AD7B4DQ47140416-4E0D497C-6C65-490D-AAA0-CF7A60C2D4B4Q48107130-1F0B628E-C940-41DE-88F7-73EDCBDBD443Q53820719-6FFC37D0-F843-4A0C-A7EC-12E4E27B6F3D
P2860
A combination of buprenorphine and naltrexone blocks compulsive cocaine intake in rodents without producing dependence
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
A combination of buprenorphine ...... s without producing dependence
@ast
A combination of buprenorphine ...... s without producing dependence
@en
type
label
A combination of buprenorphine ...... s without producing dependence
@ast
A combination of buprenorphine ...... s without producing dependence
@en
prefLabel
A combination of buprenorphine ...... s without producing dependence
@ast
A combination of buprenorphine ...... s without producing dependence
@en
P2093
P2860
P1476
A combination of buprenorphine ...... s without producing dependence
@en
P2093
George F Koob
Joel E Schlosburg
Kaushik K Misra
Leandro F Vendruscolo
Sunmee Wee
P2860
P304
P356
10.1126/SCITRANSLMED.3003948
P407
P577
2012-08-01T00:00:00Z